Necessity of medicine production in the Netherlands undisputed during the second LIFE Sciences Conference

We 27 September 2023

Medicine shortages are still increasing in the Netherlands. Doctors and pharmacists have been sounding the alarm for some time now because crucial medicines are increasingly unavailable to patients. The need for medicine production in the Netherlands is indisputable, but how do you start and strengthen this process? This issue was central during the second edition of the LIFE Sciences Conference on Tuesday, September 26, 2023, led by chairperson Rosanne Hertzberger, in a sold-out Forum Groningen. During this conference, the LIFE Cooperative, together with partners, once again brought together the players of the Life Science & Health sector in (Northern) Netherlands, this year under the theme 'Bringing Back Drug Manufacturing to the Netherlands'.

“I am convinced that in the Netherlands, we can work together towards a strategy that reduces our dependence on foreign countries when it comes to drug development and production. Collaboration is embedded in all of our DNA, and today’s event at Forum Groningen has proven this once again. It’s fantastic to be part of this informal and innovative community in Northern Netherlands,” said keynote speaker Hans Schikan, Top Team Member Life Sciences & Health at Health~Holland.

After Hans Schikan’s keynote session, participants divided into three breakout sessions to gain further inspiration. Among the speakers were Weite Oldenziel, CEO of Ofichem Group, as well as Marieke Meulemans and Brigitte Drees representing PharmaNL, and Ton Rademaker from HTRIC.

Ambitious Objectives

In addition to the development and availability of medicines, the advancement of innovative medical equipment is also a key focus within the LIFE Cooperative. This Northern collaborative network of companies and organizations in the Life Science & Health sector in the Northern Netherlands aims to drive innovation and enhance the sector's societal impact through synergy and knowledge sharing.

During the conference, the cooperative’s ambitious goals were clearly outlined. “It is evident that the return of medicine production to the Netherlands is no longer merely a wish but a necessity. The life sciences sector in the North is well-equipped to play an active role in this, focusing on development and production in collaboration with Dutch and European partners,” said Ton Vries, chairman of the LIFE Cooperative.

Awards

The second part of the conference centered on the LIFE Science Innovation Award, which recognizes innovations with significant impact in life sciences and health originating from Northern Netherlands. The award includes a €5,000 prize. From all submissions and nominations, Protyon, Griphingo Pharmaceuticals, XVIVO, and PureIMS were selected as the four finalists. Following an exciting round of pitches, PureIMS emerged as the winner. They received the rotating trophy, specially designed for the LIFE Science Innovation Award by Woodewide Cities.

Over de LIFE Cooperative

The LIFE Cooperative is the Northern collaborative network in life sciences and medical technology. Established in 2015, the cooperative strives to strengthen innovation capacity through effective and efficient collaboration. The LIFE Cooperative has a significant impact on the Life Sciences & Health sector in Northern Netherlands, representing more than 50 companies—from startups and SMEs to international players—5,000 FTEs, and €500 million in revenue.
Learn more: www.lifecooperative.nl

The Life Science Conference 2023 was made possible thanks to:
Municipality of Groningen, NV NOM, Health Holland, BOOM, Open Diagnostics, HTRIC, Ofichem, TalentMark, ICON, Campus Groningen, and Kadans Science Partner.

Maybe also interesting for you

LIFE Cooperative
LIFE Cooperative

With the launch of LIFE Capital, the Northern Netherlands gains a powerful collaboration platform that brings together companies, talent, and knowledge institutions in the fast-growing Life Sciences & Health sector. During a special launch dinner on Tuesday, November 25 at LIFE Cooperative member Polyvation on the Groningen Campus, not only was the new brand unveiled, but an ambitious vision for the future was also presented. LIFE Capital, formerly LIFE Academy, marks the next phase of the LIFE Cooperative: shifting from a focus on training alone to a broadly supported collaboration platform for human capital. “With LIFE Capital we are taking the next step in strengthening our sector,” says Melloney Dröge, board member of the LIFE Cooperative. “We are bringing companies, talent, and knowledge together into one ecosystem where growth, learning, and innovation go hand in hand. We are aiming for a joint approach to the human capital challenges of our sector. In this way, we are building a region where you can truly move forward for a lifetime, literally and figuratively.”From LIFE Academy to LIFE Capital The transition from LIFE Academy to LIFE Capital is more than a name change. The new brand reflects the organization’s growth and its ambition to look beyond training alone. LIFE Capital will become the linchpin of human capital in the Life Sciences & Health sector: it connects talent, companies, and knowledge, accelerates collaboration, and strengthens the position of the Northern Netherlands as a breeding ground for innovation and talent. A long and healthy life: that is ultimately what Life Sciences & Health is all about. Thanks to innovations from companies in this sector, diseases are detected sooner, treated more effectively, and sometimes even prevented. From breakthrough therapies to keeping healthcare affordable and accessible, the business community acts as the engine behind life-changing progress. LIFE Capital aims to strengthen that foundation by investing in people, knowledge, and collaboration. “LIFE Capital helps companies move forward, but also strengthens the image and visibility of our sector,” says Sven Stielstra, Manager of LIFE Capital. “In this way, we show what Life Sciences & Health truly stands for and make the sector attractive to new talent and innovative companies. Over the next ten years, we will attract €50 million for human capital. In this first year alone, we have already realized €6.6 million through regional and national funds.”Looking ahead: recruitment campaign and pilots in 2026 Today, the day after the launch dinner, LIFE Capital’s recruitment campaign begins. This campaign focuses on attracting participants for the first pilot modules, which will start in spring 2026. These modules were developed thanks to an intensive and unique collaboration between Hanze, UMCG, and various companies within the sector. By combining knowledge and practical experience, top-notch programmes have been created that will be tested in the coming period. After the pilot phase, the modules will be further developed and made more widely available later in 2026 to everyone in the Northern Netherlands who wishes to contribute to a strong Life Sciences & Health ecosystem.About LIFE Capital LIFE Capital is the collaboration platform of the LIFE Cooperative, a network of more than 60 companies in the Life Sciences & Health sector. The platform connects organisations around shared human capital challenges and develops solutions that attract, develop, and retain talent. What started ten years ago as separate initiatives within the cooperative has grown into a strategic programme in which companies, knowledge institutions, and governments work together on a structural basis. With activities ranging from joint training and HR networks to new educational programmes and labour market research, LIFE Capital works towards one goal: a strong, agile region in which talent in life sciences & health can continue to grow with the right skills. Move people forward.About LIFE Cooperative The LIFE Cooperative stimulates innovation in the life sciences by facilitating collaboration between entrepreneurs, researchers, and investors. Through various programmes and events, LIFE promotes the development of technologies that improve health and well-being. The cooperative represents more than 60 companies in the Northern Netherlands, ranging from ambitious startups and innovative SMEs to international players. Together, they represent approximately 5,000 FTEs and a turnover of €500 million.

LIFE Cooperative
LIFE Cooperative

Accelerating Sustainability in Healthcare Paulina Snijders, member of the UMCG Executive Board, and Bart Volkers, director of the Circular Groningen Drenthe Association (VCGD), opened the executive network meeting. They emphasized the importance of cooperation between all partners. Artist Maria Koijck delivered an inspiring keynote on visualizing hospital waste. UMCG Chief Green Officer Schelto Kruijff outlined opportunities to accelerate sustainability in healthcare, sharing inspiring examples such as the use of a washable, reusable insulation gown. Project leaders Sven Jurgens and Femke van der Zant described how the consortium has significantly developed in recent times.Various Work Packages The executives exchanged extensive experience and knowledge, and the Care2Change work package leaders presented posters. The work packages focus on areas such as redesigning single-use healthcare products and mapping the CO₂ emissions of products. Sven Jurgens said: “Care2Change is the starting point for continued collaboration on making healthcare more sustainable. How valuable it would be if, through this collaboration, we could provide a blueprint for others to inspire them to go green as well.”Northern Netherlands as an Example Hanneke Bouwsema, secretary to the special government representative for the circular economy at the Ministry of Infrastructure and Water Management, emphasized the importance of starting small and recognizing the sustainable initiatives that are already working well. She described the Northern Netherlands as a “role model” for The Hague when it comes to making healthcare more sustainable.About the Care2Change Consortium Care2Change is a collaboration between UMCG, University of Groningen, Martini Hospital, Sterinoord, GS1/EAN Netherlands, Boikon, Ommelander Hospital, Treant, Frisius MC, NHL Stenden, Hanze University of Applied Sciences, Circular Friesland Association, LIFE Cooperative, Circular Groningen Drenthe Association, Green Chemistry Drenthe Business Network (SUSPACC), Milieuplatform Zorg, Nij Smellinghe, Pezy Product Design, 8D Games, House of Design, Antonius Hospital, NOM, Menzis, De Friesland, Ecoras, BBENG, the provinces of Groningen and Drenthe, and the municipalities of Groningen, Assen, Leeuwarden and Emmen. The project is partly funded by SNN’s ERDF resources, with co-financing from the participating organizations.More Information Want to know more about Care2Change and the consortium? Read: UMCG trots op nieuwe samenwerking die uitstoot terugdringt: Care2change Source article: Care2Change

LIFE Cooperative
LIFE Cooperative

Recently, the LIFE Cooperative, together with the University Medical Center Groningen (UMCG), has been working hard on submitting projects to PharmaNL.

Preference